Dr. Fecarotta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9305 W Thomas Rd
Ste 460
Phoenix, AZ 85037Phone+1 602-933-3937Fax+1 602-933-2409
Education & Training
Indiana University School of MedicineFellowship, Pediatric Ophthalmology, 2011 - 2012
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2008 - 2011
St Joseph's HealthInternship, Transitional Year, 2007 - 2008
SUNY Upstate Medical UniversityClass of 2007
Certifications & Licensure
HI State Medical License 2022 - 2026
AK State Medical License 2021 - 2026
MT State Medical License 2020 - 2026
ND State Medical License 2020 - 2026
NE State Medical License 2020 - 2026
IL State Medical License 2020 - 2026
NH State Medical License 2020 - 2026- American Board of Ophthalmology Ophthalmology
- Join now to see all
Publications & Presentations
PubMed
- 63 citationsBevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.Gary Shienbaum, Omesh P. Gupta, Christopher Fecarotta, Avni H. Patel, Richard S. Kaiser
American Journal of Ophthalmology. 2012-03-01 - 229 citationsA treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact.Omesh P. Gupta, Gary Shienbaum, Avni H. Patel, Christopher Fecarotta, Richard S. Kaiser
Ophthalmology. 2010-11-01 - 11 citationsRefractive surgery in children.Christopher M Fecarotta, Marie Kim, Barry N Wasserman
Current Opinion in Ophthalmology. 2010-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
